Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. [electronic resource]
Producer: 20061027Description: 789-96; discussion 796-7 p. digitalISSN:- 1524-4040
- Abciximab
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Arterial Occlusive Diseases -- complications
- Brain Ischemia -- complications
- Carotid Arteries
- Cerebral Angiography
- Cerebral Hemorrhage -- chemically induced
- Female
- Fibrinolytic Agents -- administration & dosage
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Injections, Intra-Arterial
- Injections, Intravenous
- Male
- Middle Aged
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Recombinant Proteins -- administration & dosage
- Stroke -- drug therapy
- Tissue Plasminogen Activator -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.